Aurinia Pharmaceuticals Inc. (AUPH) scores 67 out of 100 on boothcheck's 11-model valuation framework. Verdict: Hold The estimated fair value is $40.29, representing a 177% margin of safety. Quantitative score: 75/100. Qualitative score: 50/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.